Manzanares C et al. |
Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636513
|
Frei U and Wagner K |
Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. |
1994 |
Transplant. Proc. |
pmid:7527963
|
Abou-Jaoude MM et al. |
Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients. |
2003 |
Transplant. Proc. |
pmid:14612103
|
Park K et al. |
Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study. |
2000 |
Transplant. Proc. |
pmid:11119901
|
Lane BC et al. |
Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7679829
|
Yu L et al. |
Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation. |
2000 |
Transplant. Proc. |
pmid:11119902
|
Christians U et al. |
High performance liquid chromatography/mass spectrometry of FK 506 and its metabolites in blood, bile, and urine of liver grafted patients. |
1991 |
Transplant. Proc. |
pmid:1721262
|
Regazzi MB et al. |
Interaction between FK 506 and diltiazem in an animal model. |
1996 |
Transplant. Proc. |
pmid:8623215
|
Ma A et al. |
Immunological evaluation of combination therapy with tacrolimus and sirolimus on long-term allograft survival in nonhuman primates. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808578
|
Cadoff EM et al. |
Assay of FK 506 in plasma. |
1990 |
Transplant. Proc. |
pmid:1689898
|
Rahamimov R et al. |
Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol. |
2003 |
Transplant. Proc. |
pmid:12644082
|
Wasserberg N et al. |
Tacrolimus does not upregulate mucin gene expression after small bowel transplantation in rats. |
2003 |
Transplant. Proc. |
pmid:12644089
|
Sgrosso JL et al. |
Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine. |
2002 |
Transplant. Proc. |
pmid:11959214
|
Alarcón-Zurita A et al. |
Steroids withdrawal after 3 months of successful renal transplantation using a tacrolimus- and mycophenolate-based immunosuppression. |
2002 |
Transplant. Proc. |
pmid:11959216
|
Rudich SM et al. |
Immunosuppression using tacrolimus, mycophenolate, and prednisone following orthotopic liver transplantation: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636574
|
Pratschke J et al. |
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation: long-term results. |
1998 |
Transplant. Proc. |
pmid:9636575
|
Imamura M et al. |
FK 506 inhibits severe graft-versus-host disease without mediating cytokine balance and/or cytotoxic molecules. |
2000 |
Transplant. Proc. |
pmid:11120238
|
Serrano M et al. |
Clinical value of a single determination of intracellular ATP levels in stimulated CD4+ T lymphocytes in pediatric patients with stable liver transplantation. |
2012 |
Transplant. Proc. |
pmid:23146475
|
DÃaz-Molina B et al. |
Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation. |
2012 |
Transplant. Proc. |
pmid:23146479
|
Forsythe J |
Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. |
1999 |
Transplant. Proc. |
pmid:10576049
|
Liu M et al. |
C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil. |
2004 |
Transplant. Proc. |
pmid:15518760
|
Ullman KS et al. |
Site of action of cyclosporine and FK 506 in the pathways of communication between the T-lymphocyte antigen receptor and the early activation genes. |
1991 |
Transplant. Proc. |
pmid:1721294
|
Yang S et al. |
Characteristics of long-term immunosuppressive therapy in Chinese pediatric renal transplant patients: a single-center experience. |
2009 |
Transplant. Proc. |
pmid:20005361
|
Seymen P et al. |
Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters. |
2009 |
Transplant. Proc. |
pmid:20005364
|
Nassar CA et al. |
Effects of long-term FK 506 therapy on the alveolar bone and cementum of rats. |
2009 |
Transplant. Proc. |
pmid:19545747
|
Karabulut AB and Ara C |
Melatonin ameliorates tacrolimus (FK-506)'s induced immunosupressive effect in rat liver. |
2009 |
Transplant. Proc. |
pmid:19545748
|
Marente VC et al. |
Modigraf administration through jejunostomy in liver transplant recipient: case report. |
2013 |
Transplant. Proc. |
pmid:24314992
|
Niederstadt C et al. |
Effect of FK506 on magnesium homeostasis after renal transplantation. |
1997 |
Transplant. Proc. |
pmid:9365709
|
Vischi S et al. |
The maltose absorption test does not predict allograft rejection of small bowel transplantation in FK 506 immunosuppressed pigs. |
1994 |
Transplant. Proc. |
pmid:7518143
|
Moscicka M et al. |
The effect of cyclosporine and tacrolimus on indigenous bacterial flora in human skin grafts. |
2003 |
Transplant. Proc. |
pmid:14529942
|
Bahra M et al. |
Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss. |
2005 |
Transplant. Proc. |
pmid:15919436
|
Kuriata-Kordek M et al. |
The influence of calcineurin inhibitors on mycophenolic acid pharmacokinetics. |
2003 |
Transplant. Proc. |
pmid:14529944
|
Ricordi C et al. |
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. |
1992 |
Transplant. Proc. |
pmid:1376512
|
Vargas V et al. |
Alpha-interferon for acute hepatitis C in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533374
|
Hisanaga M et al. |
Successful combination therapy with FK 506 and 15-deoxyspergualin in pancreatic islet xenografting. |
1992 |
Transplant. Proc. |
pmid:1376513
|
Chiang Y et al. |
Posttransplantation Kaposi sarcoma-experience in a patient receiving FK-506 and MMF. |
2003 |
Transplant. Proc. |
pmid:12591389
|
Cooper MH et al. |
Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. |
1991 |
Transplant. Proc. |
pmid:1721326
|
Maes BD and Vanrenterghem YF |
Cyclosporine: advantages versus disadvantages vis-Ã -vis tacrolimus. |
2004 |
Transplant. Proc. |
pmid:15041305
|
Didlake R and Grogan J |
Effect of FK 506 on rat leukocyte chemotaxis. |
1991 |
Transplant. Proc. |
pmid:1721327
|
Malireddy SR et al. |
Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report. |
2008 |
Transplant. Proc. |
pmid:18589198
|
Chen JW et al. |
Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176460
|
Costa A et al. |
Small bowel myoelectrical activity after transplantation in pigs: motility versus ACR score. |
1997 |
Transplant. Proc. |
pmid:9142281
|
Chmiel B et al. |
Rheological properties of red blood cells in kidney transplant recipients: the role of lipid profile and type of immunosuppresion. |
2005 |
Transplant. Proc. |
pmid:15919493
|
Prasad GV et al. |
Role of dietary salt intake in posttransplant hypertension with tacrolimus-based immunosuppression. |
2005 |
Transplant. Proc. |
pmid:15919496
|
Sakamoto K et al. |
Sodium-losing nephropathy and distal tubular damage of transplant kidneys with FK506 administration. |
1995 |
Transplant. Proc. |
pmid:7533434
|
Armitage JM et al. |
The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. |
1991 |
Transplant. Proc. |
pmid:1721358
|
Barten MJ et al. |
Pharmacodynamics of the immunosuppressive effects of the combination of tacrolimus with mycophenolate mofetil. |
2002 |
Transplant. Proc. |
pmid:12270442
|
Nalesnik MA et al. |
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population. |
1991 |
Transplant. Proc. |
pmid:1703335
|
Yoshimura N et al. |
Safety analysis following tacrolimus immunosuppression in renal transplant recipients in Japan: 3-year results in over 1000 patients. |
2002 |
Transplant. Proc. |
pmid:12176501
|
Takahashi K et al. |
Successful results after 3 years' tacrolimus immunosuppression in ABO-incompatible kidney transplantation recipients in Japan. |
2002 |
Transplant. Proc. |
pmid:12176502
|
Malaise J et al. |
Immunosuppressive drugs after simultaneous pancreas-kidney transplantation. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182827
|
Zmonarski SC et al. |
Lowering of Messenger Ribonucleic Acid Toll-Like Receptors 2-4,9 in Peripheral Blood Mononuclear Cells in Kidney Allograft Recipients, Relationships With Immunosuppressive Treatment, and Delayed Graft Function Occurrence. |
2016 |
Transplant. Proc. |
pmid:27496439
|
Hung CM et al. |
Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan. |
1998 |
Transplant. Proc. |
pmid:9838572
|
Cheng HM et al. |
Primary prophylaxis with tacrolimus in kidney transplants in China. |
1998 |
Transplant. Proc. |
pmid:9838573
|
Miller J |
Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083106
|
Undre NA et al. |
Low systemic exposure to tacrolimus correlates with acute rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083114
|
Busuttil RW and Holt CD |
Tacrolimus (FK506) is superior to cyclosporine in liver transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123119
|
Gavlik A et al. |
Mycophenolate mofetil rescue therapy in liver transplant recipients. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123124
|
Namieno T and Uchino J |
Comparative study of the effects of cyclosporine and FK 506 on rat hepatocytes cocultured with nonparenchymal liver cells. |
1996 |
Transplant. Proc. |
pmid:8908147
|
Arita C et al. |
Effect of FK 506 (FR 900506) on collagen arthritis in rats: a preliminary report. |
1989 |
Transplant. Proc. |
pmid:2468206
|
Tze WJ et al. |
Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. |
1991 |
Transplant. Proc. |
pmid:1721391
|
Morimoto T et al. |
Blood levels of FK506 after intramuscular and intravenous administration in dogs. |
1989 |
Transplant. Proc. |
pmid:2468207
|
Doi R et al. |
Mechanisms by which FK 506 affects exocrine pancreas in rats. |
1991 |
Transplant. Proc. |
pmid:1721392
|
Han DJ et al. |
A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen. |
2012 |
Transplant. Proc. |
pmid:22310592
|
Bilbao I et al. |
Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation. |
2001 |
Transplant. Proc. |
pmid:11377472
|
van Duijnhoven EM et al. |
Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176552
|
Park JW et al. |
Invasive pulmonary aspergillosis after living donor liver transplantation should be eradicated or not? A case report. |
2011 Jul-Aug |
Transplant. Proc. |
pmid:21839284
|
Chang HR et al. |
Lack of hepatotoxicity upon sirolimus addition to a calcineurin inhibitor-based regimen in hepatitis virus-positive renal transplant recipients. |
2007 |
Transplant. Proc. |
pmid:17580178
|
Weinbroum AA et al. |
Lack of cumulative effect of tacrolimus and low flow on a rat isolated liver. |
2001 |
Transplant. Proc. |
pmid:11543812
|
Zuckermann A et al. |
Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083518
|
Canivet C et al. |
T-cell function in maintenance renal transplant patients receiving mycophenolate mofetil and steroids with or without tacrolimus. |
2008 |
Transplant. Proc. |
pmid:19100403
|
Ohdan H et al. |
Prolongation of hamster-to-rat liver xenograft survival by donor bone marrow augmentation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123589
|
Mabuchi M et al. |
Insulin-like growth factor-I enhances choleretic action of FK506 in rats. |
2003 |
Transplant. Proc. |
pmid:12826230
|
Cooper MH et al. |
Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506. |
1991 |
Transplant. Proc. |
pmid:1721421
|
Yoshida Y et al. |
Effect of lipoprostaglandin E1 in concordant xenografts. |
1996 |
Transplant. Proc. |
pmid:8658716
|
McLaughlin GE et al. |
Use of phenobarbital in the management of acute tacrolimus toxicity: a case report. |
2000 |
Transplant. Proc. |
pmid:10812158
|
Levy GA |
Neoral use in the liver transplant recipient. |
2000 |
Transplant. Proc. |
pmid:10814745
|
Tahir W et al. |
Diffuse Alveolar haemorrhage: a fatal complication after alemtuzumab induction therapy in renal transplantation. |
|
Transplant. Proc. |
pmid:25645795
|
Lo A et al. |
Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12742477
|
Russ GR et al. |
Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients. |
2003 |
Transplant. Proc. |
pmid:12742480
|
El-Sabrout R et al. |
Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176636
|
Ciancio G et al. |
Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176637
|
Kovarik JM et al. |
Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus. |
2006 |
Transplant. Proc. |
pmid:17175302
|
Moura Neto A et al. |
Clinical Profile of Patients With Diabetes Mellitus and Liver Transplantation: Results After a Multidisciplinary Team Intervention. |
2018 |
Transplant. Proc. |
pmid:29661438
|
Wu M et al. |
Cyclosporine and tacrolimus alter renin-angiotesin system in mouse medullary-thick ascending limb cultured cells. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267198
|
Luke PP et al. |
IVIG rescue therapy in renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267206
|
Halloran PF et al. |
Calcineurin and the biological effect of cyclosporine and tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9723430
|
Walgenbach KJ et al. |
Upregulation of basic fibroblast growth factor during chronic rejection of rat intestinal allografts and its downregulation by FK 506. |
1998 |
Transplant. Proc. |
pmid:9745501
|
Vanrenterghem Y |
Tacrolimus (FK 506) in kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9723431
|
Murio JE et al. |
Compassionate use of FK 506 in liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7544501
|
Chamienia A et al. |
Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results. |
2014 |
Transplant. Proc. |
pmid:25380901
|
Sainsbury TS et al. |
Differential effects of FK 506 and cyclosporine on hair regrowth in the DEBR model of alopecia areata. |
1991 |
Transplant. Proc. |
pmid:1721453
|
Kocak H et al. |
Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose. |
2005 |
Transplant. Proc. |
pmid:16213288
|
Abou-Jaoude MM et al. |
Tacrolimus (FK506) versus cyclosporine microemulsion (neoral) as maintenance immunosuppression therapy in kidney transplant recipients. |
2005 |
Transplant. Proc. |
pmid:16213293
|
Jordan ML et al. |
Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267456
|
Abe T et al. |
Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation. |
2014 |
Transplant. Proc. |
pmid:24767367
|
Li S et al. |
Intrathymic inoculation of donor bone marrow at the time of transplantation plus a short course of tacrolimus induce long-term acceptance to rat lung allografts. |
1998 |
Transplant. Proc. |
pmid:9636431
|
Miyagawa S et al. |
Mechanism of unresponsiveness in rats induced by a short course of FK 506 or CyA. |
1991 |
Transplant. Proc. |
pmid:1703687
|
Carroll PB et al. |
Effect of the immunosuppressant FK 506 on insulin release from adult rat islets of Langerhans. |
1991 |
Transplant. Proc. |
pmid:1703688
|
Pridöhl O et al. |
Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750384
|